SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : NexOptic Technology Corp
NXOPF 0.00400-20.0%Oct 31 9:30 AM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: togrok4/7/2021 10:24:39 AM
   of 110
 
Pristine Surgical and NexOptic Announce Commercial Agreement To Use AI for Single-Use Surgical Endoscopy Explains NexOptic Chairman Rich Geruson April 7, 2021

Pristine Surgical and NexOptic enter into an exclusive agreement to deploy NexOptic’s AI-powered image processing neural network in Pristine’s single-use endoscopic visualization platform

April 7, 2021 (Manchester, N.H. and Vancouver, B.C.) – Pristine Surgical LLC and NexOptic Technology Corp. (“NexOptic”) (TSX VENTURE: NXO) (OTCQB: NXOPF) (FSE: E3O1) announced that they have entered into an exclusive partnership to deploy NexOptic’s artificial intelligence (AI) powered imaging technology in Pristine’s single-use endoscopic visualization platform.

NexOptic’s proprietary neural networks, which power their All Light Intelligent Imaging Solutions (ALlIS™), are machine-learning-enabled and allow for more compact, lower-cost, lighter-weight optics with extreme low-light, anti-glare and data compression performance. Combined with faster shutter speeds and reduced motion blur on a variety of platforms, the result is always-sharper images with a myriad of downstream processing advantages.

Pristine Surgical’s single-use endoscopes use high-performance digital image sensors, advanced high-brightness LEDs and powerful graphics-processing hardware and software to deliver high-definition, high-quality images in a single-use surgical endoscope at reduced cost.

The companies will work together to incorporate NexOptic’s Aliis technology into Pristine’s single-use endoscopic visualization platform for image optimization.

“At Pristine, we are able to increase patient safety, improve economics and efficiency and advance the state of the art in endoscopy by incorporating powerful, cutting-edge technologies in a single-use visualization platform,” said Bryan Lord, CEO of Pristine Surgical. “We’re excited to work with NexOptic to use their ALlIS platform to advance our deployment of artificial intelligence capabilities and help us further that mission.”

“Pristine has built the endoscopy platform of the future. By combining our AI expertise with their unique single-use scope design, there’s an immediate opportunity to further advance the surgical visualization platform of tomorrow,” added Paul McKenzie, CEO of NexOptic Technologies. “Today’s announcement is a milestone for NexOptic’s artificial intelligence imaging solutions. I look forward to the future and fully anticipate signing additional clients this year.”

“This is a revolutionary solution that could help millions of patients annually and ensure surgeons can do their jobs in a safer manner, and more effectively,” said Rich Geruson, NexOptic Chairman.

About Pristine Surgical

Pristine Surgical LLC is a single-use surgical visualization company dedicated to improving patient care, safety and efficacy for the more than 25 million endoscopic (arthroscopy and laparoscopy) procedures performed worldwide each year. Pristine’s platform combines high-performance digital image sensors, advanced high-brightness LEDs and powerful graphics processing hardware and software with Pristine Connect, a cloud-based SaaS platform which makes the full surgical episode more efficient for patient, surgeon and surgery center. Pristine’s single-use design eliminates the risks posed by cross-contamination, reduces sterilization and maintenance costs and provides consistently clear images, every time. Headquartered in Manchester, N.H., Pristine Surgical is led by an experienced management team, a seven-person board of managers and a 10-person medical advisory board. For more information on how we See Beyond™, visit pristinesurgical.com.

About NexOptic Technology Corp.

NexOptic is an innovative imaging AI company headquartered in Vancouver, Canada with operations in Seoul, South Korea, offering a world-leading AI platform for imaging known as ALIIS™ (All Light Intelligent Imaging Solutions). NexOptic simultaneously influences the optics and AI industries and is a Preferred Partner in the NVIDIA Partner Network, a member of the Arm® AI Partner Program, and a member of the Qualcomm® Platform Solutions Ecosystem. For more information, visit www.nexoptic.com.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext